Hosting the preparation meeting of the Online Pharmacogenomics and Personalized Medicine postgraduate program (OPPM), which is held for the first time in the Middle East
Hospital 57357 welcomed members of the OPPM program, Dr. Mervat Amin, the dean of Pharmacy Faculty, Alexandria University, accompanied by a group of the faculty’s professors. We were also honored to welcome representatives of Nile University, the Ministry of Communication, Faculty of Pharmacy, Alfayoum University, Magdi Yacoub Hospital and Al-Alfi organization, to attend the proceedings of the signing of a cooperation protocol between 57357 and Faculty of Pharmacy, Alexandria University. The guests were welcomed by Dr. Sherif Abouel Naga, CEO of 57357 group and the Hospital’s General Manager, Dr. Mohamed Nagui, head of the clinical pharmacy and his deputy Dr. Ibrahim Abdo, and a group of the Hospital’s management and doctors.
A cooperation protocol between Hospital 57357 and the Faculty of Pharmacy, Alexandria University was signed, in attendance of Dr. Abouel Naga and Dr. Amin. The protocol includes everything related to pharmacy including new specialized training programs such as Pharmacogenomics and other specializations in the field of clinical pharmacy, as well as training to obtain certifications. As such, 57357 would become one of the training centers that Alexandria University would depend on, knowing that Hospital 57357 is one of the best training centers in clinical pharmacy.
On the side line of the cooperation protocol signing, the third preparation meeting of OPPM was held online. This is a program for post graduate study of Pharmacogenomics, funded by the European Union. Thirteen academic and none-academic entities will participate in the program, these are three Egyptian Universities, Alexandria, Alfayoum and Alnile, four European Universities, Newcastle University in England, Oviedo University in Spain, Kiel University (CAU) in Germany and DUTH University of Greece, two universities in Lebanon, the American University in Beirut, and Beirut Arab University, with the participation of three civil society organizations, the Children’s Cancer Hospital Foundation 57357, Al-Alfi Foundation and Magdi Yacoub Hospital in addition to the Ministry of Communication and Technology.
It is noteworthy that this program is organized for the first time in the Middle East, and working on it started a year ago. The meeting held in 57357 included representatives of the Nile University, faculties of Pharmacy of Alexandria and Alfaioum Universities, the Ministry of Communication, Magdi Yacoub Hospital and Al-Alfi Foundation.
Dr. Abouel Naga welcomed the attendees, expressing his happiness with what he referred to as a “real science board”. He spoke about Hospital 57357’s strategy of relying on evidence-based practices and putting knowledge and science into action. He described the project as a step on the road of reducing treatment cost, adjusting doses and reducing side effects. “We need to cooperate in harmony to reach common grounds so that we would achieve our goals”, said Dr. Abouel Naga. He shared how 57357 places research, education and training within its priorities, aiming to offer the best treatment and care to its patients. He talked about 57357’s pursuit of quality and its leadership in the field of clinical pharmacy application and training. Through collaborations with different universities, hospitals and scientific institutions, the Hospital contributes to offering training and education to pharmacists, doctors and students, aiming to raise the level of healthcare provided to patients, he added.
Dr. Mohamed Nagui, head of 57357’s clinical pharmacy revealed that the program will be ready to be launched by the end of 2024, to obtain online diploma and a master’s degree in Pharmacogenomics, for the first time in the Middle East and Africa. By the end of this year, some short term certificates will be available through the project, in cooperation between 57357, Alexandria University and some of the project’s participants.
At the end of the meeting, the guests toured the Hospital where they visited the clinical pharmacy and its different sub-departments and other departments such as the research department. They visited the cyberknife, which is the latest technology in radiotherapy. They were impressed with the advanced technology offered by the Hospital and the Hospital’s pursuit of making available the world latest technology to offer the best care to sick children. They also expressed their delight with the Hospital’s concern to offer psychological care besides physical care. They affirmed their gladness for collaborating with 57357 in the Pharmacogenomics program.